Biotechking

REGN projection to 750 analyst target

做多
Biotechking 已更新   
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Used the pitch fork tool to determine when the current trend would align with the new analyst target of 750. First time using tool. Please provide feedback.
评论:
Going to breakout or down. Earnings aug 5. I’ll beat up.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。